Anti-HIV agents at ICAAC.
Copyright policy )Anti-HIV agents at ICAAC.
Nelfinavir, AIDS-Related Opportunistic Infections, Organophosphonates, Drug Resistance, Microbial, Drug Synergism, HIV Infections, HIV Protease Inhibitors, Isoquinolines, Kidney, Antiviral Agents, CD4 Lymphocyte Count, Cytosine, Organophosphorus Compounds, Cytomegalovirus Retinitis, Mutation, HIV-1, Humans, Reverse Transcriptase Inhibitors, Drug Therapy, Combination, Cidofovir
Nelfinavir, AIDS-Related Opportunistic Infections, Organophosphonates, Drug Resistance, Microbial, Drug Synergism, HIV Infections, HIV Protease Inhibitors, Isoquinolines, Kidney, Antiviral Agents, CD4 Lymphocyte Count, Cytosine, Organophosphorus Compounds, Cytomegalovirus Retinitis, Mutation, HIV-1, Humans, Reverse Transcriptase Inhibitors, Drug Therapy, Combination, Cidofovir
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).0 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!